We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+10.56%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$120B
AUM Growth
+$5B
(+4.4%)
Cap. Flow
-$4.23B
Cap. Flow
% of AUM
-3.53%
Top 10 Holdings %
Top 10 Hldgs %
33.52%
Holding
335
New
4
Increased
58
Reduced
216
Closed
7
Avg Time Held
6
years
Top 10 Avg Time Held
5.4
years
Top 20 Avg Time Held
5.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$227M |
| 2 |
GSK
GSK
|
+$68.2M |
| 3 |
Elanco Animal Health
ELAN
|
+$48.2M |
| 4 |
Intel
INTC
|
+$45M |
| 5 |
Capri Holdings
CPRI
|
+$44.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$764M |
| 2 |
Microsoft
MSFT
|
+$272M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$262M |
| 4 |
Caterpillar
CAT
|
+$148M |
| 5 |
Novartis
NVS
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.41% |
| 2 | Technology | 30.05% |
| 3 | Industrials | 12.22% |
| 4 | Consumer Discretionary | 9.43% |
| 5 | Financials | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
326
Mereo BioPharma
MREO
$49.4M
| $208K | ﹤0.01% |
157,700
-138,830
| -47% | -$161K |
2019 Q2
16 quarters
|
|
327
908 Devices
MASS
$491M
| $184K | ﹤0.01% |
26,870
| – | – |
2020 Q4
10 quarters
|
|
328
DELISTED
GAN Ltd
GAN
| $117K | ﹤0.01% |
71,600
-555,380
| -89% | -$791K |
2020 Q2
12 quarters
|
|
329
DELISTED
Calavo Growers
CVGW
| – | – |
-7,600
| Closed | -$219K | – |
|
330
DELISTED
Faro Technologies
FARO
| – | – |
-12,800
| Closed | -$315K | – |
|
331
Grocery Outlet
GO
$1.29B
| – | – |
-10,000
| Closed | -$283K | – |
|
332
US Bancorp
USB
$89.4B
| – | – |
-442,700
| Closed | -$16M | – |
|
333
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
| – | – |
-833
| Closed | -$42.2K | – |
|
|
TSP
334
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| – | – |
-32,000
| Closed | -$47K | – |
|
|
MAXR
335
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| – | – |
-528,150
| Closed | -$27M | – |
|
Similar funds
Primecap Management's Q2 2023 Portfolio in Review
As of Q2 2023, Primecap Management held 335 positions worth $120B, up 4.4% from $115B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Primecap Management withdrew a net $4.23B in Q2 2023, closing 7 positions and reducing 216 holdings. Its most notable exit was Maxar Technologies Inc. Common Stock, an estimated $27M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Industrials.
Against the trend, Primecap Management opened a new position in Sphere Entertainment worth $17.1M.
- Primecap Management's largest Q2 2023 buy was Sphere Entertainment: 623,078 shares worth $17.1M.
- Primecap Management added most to Seagen Inc. Common Stock in Q2 2023, an estimated $227M increase.
- Primecap Management's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $764M.
- Primecap Management fully exited Maxar Technologies Inc. Common Stock in Q2 2023, selling an estimated $27M.
- Primecap Management's ten largest holdings make up 34% of its $120B portfolio in Q2 2023.
- Primecap Management opened 4 new positions and closed 7 in Q2 2023.
- Primecap Management's portfolio value rose 4.4% quarter-over-quarter to $120B.
Based on Primecap Management's 13F filing for Q2 2023, filed 11 Aug 2023.